Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Hepatocellular carcinoma: A global view.

Yang JD, Roberts LR.

Nat Rev Gastroenterol Hepatol. 2010 Aug;7(8):448-58. doi: 10.1038/nrgastro.2010.100. Epub 2010 Jul 13. Review.

2.

Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.

Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, Lui WY, Chang FY, Lee SD.

Liver Int. 2005 Apr;25(2):236-41.

PMID:
15780044
3.

Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.

Kew MC.

Pathol Biol (Paris). 2010 Aug;58(4):273-7. doi: 10.1016/j.patbio.2010.01.005. Epub 2010 Apr 7.

PMID:
20378277
4.

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.

Momosaki S, Nakashima Y, Kojiro M, Tabor E.

J Viral Hepat. 2005 May;12(3):325-9.

PMID:
15850475
5.

[Epidemiology of hepatocellular carcinoma in a rural area. Role of hepatotrophic viruses on survival].

Rodríguez-Vidigal FF, Baz MJ, Romero J, del Puerto M.

An Med Interna. 2005 Apr;22(4):162-6. Spanish.

PMID:
16004511
6.

The epidemiology and prevention of hepatocellular carcinoma.

Monto A, Wright TL.

Semin Oncol. 2001 Oct;28(5):441-9. Review.

PMID:
11685737
7.

Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.

Walter SR, Thein HH, Gidding HF, Amin J, Law MG, George J, Dore GJ.

J Gastroenterol Hepatol. 2011 Dec;26(12):1757-64. doi: 10.1111/j.1440-1746.2011.06785.x.

PMID:
21615789
8.
9.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
10.

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M.

J Viral Hepat. 2013 Aug;20 Suppl 2:1-20. doi: 10.1111/jvh.12120. Erratum in: J Viral Hepat. 2013 Oct;20(10):744. Hadjichristodoulou, T [corrected to Hadjichristodoulou, C].

PMID:
23827008
11.

Status quo of chronic liver diseases, including hepatocellular carcinoma, in Mongolia.

Jazag A, Puntsagdulam N, Chinburen J.

Korean J Intern Med. 2012 Jun;27(2):121-7. doi: 10.3904/kjim.2012.27.2.121. Epub 2012 May 31. Review.

12.

Hepatitis C and hepatitis B-related mortality in Spain.

García-Fulgueiras A, García-Pina R, Morant C, García-Ortuzar V, Génova R, Alvarez E.

Eur J Gastroenterol Hepatol. 2009 Aug;21(8):895-901. doi: 10.1097/MEG.0b013e328313139d. Review.

PMID:
19357523
13.

Hepatocellular carcinoma in the Asia pacific region.

Yuen MF, Hou JL, Chutaputti A; Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma.

J Gastroenterol Hepatol. 2009 Mar;24(3):346-53. doi: 10.1111/j.1440-1746.2009.05784.x. Epub 2009 Feb 12. Review.

PMID:
19220670
14.

Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.

Nguyen VT, Razali K, Amin J, Law MG, Dore GJ.

J Gastroenterol Hepatol. 2008 Jun;23(6):922-9. Epub 2007 Jul 1.

PMID:
17608637
15.

Influence of viral load and genotype in the progression of Hepatitis B-associated liver cirrhosis to hepatocellular carcinoma.

Mahmood S, Niiyama G, Kamei A, Izumi A, Nakata K, Ikeda H, Suehiro M, Kawanaka M, Togawa K, Yamada G.

Liver Int. 2005 Apr;25(2):220-5.

PMID:
15780042
16.

Association of hepatitis C virus with liver cirrhosis and hepatocellular carcinoma compared with hepatitis B virus in Egyptian patients.

Darwish MA, Amer AF, El-Moeity AA, Darwish NM.

J Egypt Public Health Assoc. 1997;72(5-6):569-89.

PMID:
17214153
17.

Infection with hepatitis B and C viruses, social class and cancer.

Stuver SO, Boschi-Pinto C, Trichopoulos D.

IARC Sci Publ. 1997;(138):319-24. Review.

PMID:
9353672
18.

Role of antiviral therapy in the management of hepatocellular carcinoma.

Guan YS, He Q.

Anticancer Drugs. 2013 Apr;24(4):337-43. doi: 10.1097/CAD.0b013e32835ec39a. Review.

PMID:
23388161
19.

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.

Oh JK, Shin HR, Lim MK, Cho H, Kim DI, Jee Y, Yun H, Yoo KY.

BMC Cancer. 2012 Oct 5;12:452. doi: 10.1186/1471-2407-12-452.

20.

Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas.

Huo TI, Wu JC, Hsia CY, Chau GY, Lui WY, Huang YH, Lee PC, Chang FY, Lee SD.

World J Surg. 2004 Aug;28(8):787-91. Epub 2004 Aug 3.

PMID:
15457359
Items per page

Supplemental Content

Write to the Help Desk